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Abstract
Backround: The transobturator tape procedure (TOT) is an effective surgical treatment of female
stress urinary incontinence. However data concerning safety are rare, follow-up is often less than
two years, and complications are probably underreported. The aim of this study was to describe
early and late complications associated with TOT procedures and identify risk factors for erosions.
Methods: It was a 27 months follow-up of a cohort of 233 women who underwent TOT with
three different types of slings (Aris®, Obtape®, TVT-O®). Follow-up information was available for
225 (96.6%) women.
Results: There were few per operative complications. Forty-eight women (21.3%) reported late
complications including de novo or worsening of preexisting urgencies (10.2%), perineal pain (2.2%),
de novo dyspareunia (9%), and vaginal erosion (7.6%). The risk of erosion significantly differed
between the three types of slings and was 4%, 17% and 0% for Aris®, Obtape® and TVT-O®
respectively (P = 0.001). The overall proportion of women satisfied by the procedure was 72.1%.
The percentage of women satisfied was significantly lower in women who experienced erosion
(29.4%) compared to women who did not (78.4%) (RR 0.14, 95% CI 0.05-0.38, P < 0.001).
Conclusion: Late post operative complications are relatively frequent after TOT and can impair
patient's satisfaction. Women should be informed of these potential complications preoperatively
and require careful follow-up after the procedure. Choice of the safest sling material is crucial as it
is a risk factor for erosion.
Background
Urinary incontinence is a major public health problem. In
Europe, it is estimated to affect up to one third of women
older than the age of 18 years. The prevalence increases
with age and reaches 45% at 60 years [1]. In 1995, the ten-
sion-free-vaginal-tape (TVT) procedure was introduced
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and has revolutionized the surgical treatment of female
stress urinary incontinence (SUI) due to its simplicity, effi-
ciency and minimal invasiveness [2]. However patients
can be exposed to several complications [3]. One category
of complications is associated with the blind passage of
the tape through the retropubic space causing bladder or
bowel perforation, or vascular injuries. The other category
is related to voiding disorders such as dysuria, or de novo
urgency. In a quest to find a minimally invasive sling asso-
ciated with even less morbidity than the TVT, the transob-
turator tape (TOT) was created [4] and a modified
procedure (TVT-O) was reported by de Leval [5]. Since its
introduction numerous reports confirmed its effectiveness
with an objective and a subjective cure rate up to 80% and
92% respectively and low morbidity [6,7]. However, com-
plications are probably underreported [8]. Recently few
articles reported high erosion rates [9,10], ischio rectal
abcess [11,12] as well as other complications. Data con-
cerning safety are rare, follow-up is often less than two
years, and risk factors for erosions are poorly described
[13].
The aim of this study was to describe the complications,
and especially late ones, associated with the transobtura-
tor sling procedure. One specific objective was to identify
risk factors for erosions.
Methods
We included 233 consecutive women who had undergone
transobturator sling procedure for pure stress or mixed
urinary incontinence in the Department of Obstetrics and
Gynecology, Geneva University Hospitals, from June
2003 to October 2006. This study was approved by the
Institutional Ethics Committee of the Geneva University
Hospitals. We collected Variables including age, weight,
height, menopausal status, hormonal replacement ther-
apy, previous hysterectomy or genital prolapse surgery.
Urodynamics was systematically performed preopera-
tively, according to the standards recommended by the
International Continence Society[14]. In women with
concomitant urge incontinence, causes were searched and
treated. All women had a standardized preoperative pro-
lapse assessment using Baden-Walker classification[15].
The operative technique used was based on Delorme's
description [4] for the outside-in technique and on De
Leval's [5] for the inside-out technique. Cystoscopy was
not systematically performed. We used three different
types of slings during the study period: ObTape® (Mentor-
Porges, Le Plessis Robinson, France), TVT-O® (Gynecare,
Johnson and Johnson, Spreitenbach, Suisse) and Aris®
(Porges, Le Plessis Robinson, France). Surgery was per-
formed by six senior surgeons. Prophylactic antibiotics
(cefoxitin 2 g intravenously) was systematically adminis-
tered.
Data about surgery, the type of sling procedure, associated
surgery, per-operative and early postoperative complica-
tions were collected in the charts. The follow up period
after TOT ranged from 5 to 50 months. Follow-up
included for all patients a clinical examination one month
after surgery by their surgeon. We also recorded data on
any assessment made during the study period in our
department. Per operative complications (vaginal perfora-
tion, haemorrhage, vesical or urethral perforation), early
post-operative complications (hematoma, dysuria, infec-
tion) and late post-operative complications (erosions,
ischio-rectal abscess, perineal pain, de novo dyspareunia,
de novo urge or impaired urge incontinence) were
searched. In case of urgencies, infection was excluded by
urine analysis. Early post-operative period was defined as
from one day to one month after surgery and late post-
operative period more than one month.
In addition, between the first of September 2007 and the
31st of December 2007 all women were contacted by tel-
ephone by one of the investigators (IKG) and asked stand-
ardized questions to complete the assessement of late
post-operative complications.
Means were compared with the t-test and proportions
with the chi-square test. A P value less than or equal to
0.05 was considered to be statistically significant and 95%
confidence intervals (CIs) were reported. We performed a
univariable analysis to compute the relative risks and their
95% CI, for each predictor of erosions. Mean intervals
from TOT procedure to events (erosion or end of follow-
up) were estimated for each type of sling from life tables
(Kaplan-Meier), and survival curves were compared by the
Peto log-rank test. The Cox model was used to calculate
hazard ratios (HRs) to adjust for the different duration of
follow-up with the various slings. Data were managed and
analyzed with SPSS 15.0 statistical software (SPSS Inc.,
Chicago, IL).
Results
Between June 2003 and December 2006, we performed
233 transobturator sling procedures for the treatment of
female stress incontinence in our institution. The charac-
teristics of the patients are reported in Table 1. The mean
follow-up was 27 months (SD = 9.7). Fifty-eight (24.9%)
patients had the TOT under loco-regional and 175
(75.1%) under general anaesthesia. TOT was the only pro-
cedure in 129 patients and was associated with another
surgical intervention in 104 women (11 total laparoscopic
hysterectomies, 33 vaginal hysterectomies, 58 vaginal
anterior repairs, 53 vaginal posterior repairs, 21 vaginal
vault suspensions to the sacrospinous ligament according
to Richter, and 22 other procedures such as conisation,
laparoscopy and hysteroscopy). The indication for TOTBMC Women's Health 2009, 9:28 http://www.biomedcentral.com/1472-6874/9/28
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was stress incontinence with pure stress incontinence in
153 (65.7%) and mixed urinary incontinence in 80
women (34.3%). The mean hospitalization duration was
3.5 days (range 1 to 19 days). For women who had only
TOT procedure, the mean hospitalization stay was 2.2
days (range 1 to 6 days) compared to 5.2 days (range 2 to
19 days) for women who had other surgical procedure
associated with the TOT (P < 0.001).
We used three types of slings: Aris®  in 101 (43.4%),
Obtape®  in 76 (32.4%) and TVT-O®  in 56 (24.0%)
women. The mean follow-up was 18.8 months (SD = 4.5),
34.3 months (SD = 8.4), and 33.3 months (SD = 5.7) for
Aris®, Obtape® and TVT-O® respectively (P < 0.001).
Six women were lost to follow-up (2 TVT-O®, 2 Obtape®
and 2 Aris®) and two had died (1 TVT-O®, 1 Obtape®) at
phone contact, leaving 225 women available for the late
post-operative analysis. The complications are reported in
table 2 and divided in per-operative complications, early
postoperative and late postoperative complications. Per-
operative complications were very rare apart from bleed-
ing more than 200 ml which occurred in 12 women
(5.2%), 8 times in women with TOT only and 4 times in
women with another additional surgical procedure. How-
ever none of the patients required blood transfusion.
There was no bladder perforation. Seven women (3%)
had urinary retention after surgery. Retention lasted less
than 72 hours for five of them (2.1%) and was success-
fully treated using a Foley catheter. Retention lasted more
than 72 hours for two women (0.9%). One of them
needed section of the sling and the other one needed
intermittent self catheterization during 15 days.
There was no difference in term of per operative and early
post operative complications between women who had
TOT procedure in addition with another surgical proce-
dure compared to women who had TOT only (RR 0.93,
95% CI 0.64-1.34, P = 0.71).
Overall late complication rate was 21.3% (48/225
women). There was no difference between women who
had concomitant procedures and women who had TOT as
an only surgical procedure (RR 0.86, 95% CI 0.59-1.27, P
= 0.45). Late postoperative complications were de novo
urgency in 14 patients (6.2%), perineal pain in five
Table 1: Characteristics of the study population
Characteristics Total N = 233
Age (y) mean (SD) 57.9 (13.2)
Height (cm) mean (SD) 1.60 (0.06)
Weight (kg) mean (SD) 70.7 (14)
BMI (kg/m2) mean (SD) 27.6 (5)
Menopause n (%) 156 (67)
HT n (%) 52 (22.3)
Menopause without HT n (%) 104 (44.6)
Pure stress incontinence n (%) 153 (65.7)
Mixed urinary incontinence n (%) 80 (34.3)
Previous hysterectomy n (%) 40 (17.2)
Previous prolapse surgery n (%) 31 (13.3)
Sexual Activity n (%) 156 (67)
BMI = body mass index; HT = hormonal replacement therapy
Table 2: Complications
Complications Total
N = 233
Obtape®
N = 76
Aris®
n = 101
TVT-O®
n = 56
P value
During procedure n (%)
Haemorrhage>200 ml 12 (5.2) 2 (2.6) 9 (8.9) 1 (1.8) 0.07
Vaginal perforation 2(0.9) 0 2 (2.0) 0 0.27
Bladder perforation 0 (0) 0 0 0 NA
Early-postoperative n (%)
Urinary retention 6 (2.6%) 3 (3.9) 1 (1.0) 2 (3.6) 0.41
Section of the sling 1(0.4%) 0 0 1 (1.8) 0.21
Haematoma 1(0.4%) 0 0 1 (1.8) 0.21
Late post-operative* n (%)
Vaginal erosions 17 (7.6%) 13 (17.8) 4 (4.0) 0 >0.001
Reintervention† 14 (6.2%) 11 (15.1) 3 (3.0) 0 0.001
Abscess 1 (0.4%) 1 (1.4) 0 0 0.35
De novo dyspareunia 14 (6.2%) 7 (9.6) 5 (5.1) 2 (3.8) 0.33
De novo urgency 14 (6.2%) 8 (11.0) 2 (2.0) 4 (7.5) 0.05
Perineal pain 5 (2.2%) 2 (2.7) 2 (2.0) 1 (1.9) 0.93
Worsening of urgency 9 (4.0%) 3 (4.1) 3 (3.0) 3 (5.7) 0.73
P values are calculated with the chi-squared test
*Percentage are calculated with N = 225 (73 Obtape®, 99 Aris®, 53 TVT-O®)
†Reinterventionfor vaginal erosionBMC Women's Health 2009, 9:28 http://www.biomedcentral.com/1472-6874/9/28
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(2.2%) and aggravation of urge incontinence in nine
(4%). Dyspareunia de novo occurred in 14 patients of the
156 sexually active women (9%). As above, there was no
difference between women who had combined proce-
dures and women who had solitary TOT's for specific late
complications. Seventeen patients developed vaginal ero-
sions (7.6%) among which one developed an abscess of
the obturator fossa 38 months after insertion of the sling.
Drainage of the gluteal abscess was performed followed
by removal of the vaginal mesh and antibiotics were
administered intravenously for five days and completed
for ten days orally. The patient was discharged after one
week. At follow-up five months later, the woman was
asymptomatic and without incontinence. The mean time
from TOT procedure to diagnosis of erosion was 11
months (range 1 to 37 months). Fourteen of the 17
women with erosion (82.4%) required reintervention
with section and total or partial removal of the sling.
Three of them (17.6%) were successfully treated conserv-
atively with local estrogens and antiseptic treatment. The
size of erosion was less than one centimeter and healing
was achieved in four to 10 weeks. The proportion of ero-
sions was significantly different between the three types of
slings. There were four erosions in women treated with
Aris® (4%) compared to 13 erosions in the Obtape® group
(17.8%) (RR 0.23, 95% CI 0.08-0.67, P = 0.003). There
was no erosion in the TVT-O® group (Table 2). The differ-
ence between TVT-O® and Aris® groups was not statistically
significant (P = 0.17). The mean interval from TOT proce-
dure to diagnosis of erosion was 8.8 months (range 2 to
17 months) for Aris® and 11.7 mo (range 1 to 37 months)
for Obtape® (P = 0.6) respectively. The mean age and BMI
were similar in women with erosion compared to women
who did not present with erosion during the study period.
In time to event analysis, the difference between the three
slings was statistically significant (log-rank test 0.001)
(Fig. 1). After adjustment for the duration of follow up in
a Cox model, the hazard ratio still showed a decreased risk
of erosion in the Aris® compared with the Obtape® group
(HR 0.27, 95% CI 0.09-0.86; p = 0.03). Apart from the
type of sling, we did not identify any other significant risk
factor of erosions (Table 3).
The overall proportion of women satisfied by the proce-
dure was 72.1%. The percentage of women satisfied was
significantly lower in women who experienced erosion
(29.4%) compared to women who did not (78.4%) (RR
0.14, 95% CI 0.05-0.38, P < 0.001). Satisfaction was sig-
nificantly reduced in women who developed de novo dys-
pareunia (42.9%) and de novo urgency (35.7%) compared
to those who did not (76.8% and 77.3%, respectively)
(RR 0.25, 95% CI 0.09-0.70, P = 0.005 and RR 0.19, 95%
CI 0.07-0.54, P < 0.001, respectively). Satisfaction was
also reduced in the five women reporting perineal pain
(40%) compared to those who did not (75.5%) (RR 0.53,
95% CI 0.18-1.56, P = 0.07).
Discussion
Our study confirms that at short term, TOT is a safe proce-
dure with very few per-operative and early post operative
complications. However, during the long term follow-up,
occurrence of de novo urge symptoms, de novo dyspareu-
Table 3: Comparisons between women with and without erosions (N = 225)
Predictor Erosions
(n = 17)
No erosions
(n = 208)
Relative risk
(95% CI)
P value
Type of sling n (%)
Obtape® 13 (76.5) 60 (28.8) Réf.
Aris® 4 (23.5) 95 (45.7) 0.23 (0.08-0.67) 0.003
TVT-O® 0 53 (25.5) NA 0.001
Haemorrhage > 200 ml n (%) 2 (5.9) 10 (4.8) 2.37 (0.61-9.18) 0.22
Sexual activity n (%)
No 4 (23.5%) 65 (31.3%) Réf.
Yes 13 (76.5%) 143 (68.8%) 1.44 (0.49-4.25) 0.51
Age: mean (SD) 58.0 (13.4) 56.9 (12.3) NA 0.35
BMI: mean (SD) 27.6 (1.2) 27.7 (0.4) NA 0.39
Concomitant surgery n (%)
None 9 (52.9) 116 (55.8) Réf.
Prolapse surgery 3 (17.6%) 72 (34.6%) 0.56 (0.16-1.99) 0.36
Hysterectomy 1(5.9) 41 (19.7%) 0.33 (0.04-2.53) 0.26
Any surgery 8 (47.1) 92 (44.2) 1.11 (0.44-2.78) 0.82
Hypoestrogeny n (%)
No 12 (70.6%) 111 (53.4%) Réf.
Yes 5 (29.4%) 97 (46.6%) 0.88 (0.26-2.95) 0.84
P values are calculated with the chi-squared test for proportions and with the T-test for means unless specified.BMC Women's Health 2009, 9:28 http://www.biomedcentral.com/1472-6874/9/28
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nia, perineal pain, and vaginal erosions significantly
reduced the satisfaction of patients.
The only relevant per-operative complication, in our
study, was haemorrhage of more than 200 ml (5.2%), but
there were no haematomas, and no transfusion was
required. Different series of TOT procedures report similar
risks of bleeding rates varying between 0.83 and 5.4%
[16,17]. In a large study the incidence of intra operative
bleeding of more than 200 ml was 1.9% for the TVT pro-
cedure [3].
The incidence of urinary retention is low in our study and
is similar to the rates of 1.5% reported by other authors
[7,16]. In a recent review [18] which compared retropubic
and transobturator tapes, voiding lower urinary tract
symptoms were less common with the transobturator
route.
De novo urge symptoms have a high impact on quality of
life [19]. We observed 6.2% of women with persistent de
novo urgency at long term follow-up which is similar to
other studies [17,20]. In comparison, the risk with TVT is
reported to be higher in the short term (33% for TVT vs
8% for TOT) [21], but after a longer follow up period, the
risk is similar (6.3%) [22].
In our study, most women were sexually active (67%) and
among them 9% reported de novo dyspareunia after the
operation. This complication has a potential high impact
on the quality of life, as the overall proportion of women
satisfied with the procedure drops dramatically when it
occurs (76.8% compared to 42.9%, P = 0.005). In a recent
study [17], dyspareunia was more frequent after TOT
(19.2% compared to 16.2% before), but the finding was
not considered statistically significant. In another study,
dyspareunia was reported in eight over 78 sexually active
women (10.3%) [6]. After TVT no significant difference in
the incidence of dyspareunia was found post-operatively
[23].
Perineal pain is reported to occur in 2.3% to 5% after tran-
sobturator surgery, to be transient, resolving within the
first month [16,24]. We report the same rates, but with
persistent pain on long term follow up. The risk of groin
pain is higher with TOT and TVT-O, compared to the TVT
(OR 8.28, 95% CI 2.7-25.4) [25].
In our study 17 women had vaginal erosions. The propor-
tion of women satisfied with the procedure was signifi-
cantly reduced when erosion occurred. The mean time to
erosions varied, which emphasizes the need to pay atten-
tion when symptoms like vaginal discharge, pain or dys-
pareunia occur even after a long period. Since some
erosion occur without symptoms and can not be detected
through telephone contact, this complication might be
underestimated in our study. The majority of women who
developed erosions required a reintervention. One
woman presented with an abscess of the obturator fossa
38 months after surgery. In a recent review of suburethral
sling procedures complications [26], the frequency of ero-
sions after TOT varied between 1.8% and 20.0%. In a
recent meta-analysis [25], erosions were more common
after tape insertion by the transobturator route (TVT-O
and TOT) compared to the retropubic route (OR 1.96;
95% CI 0.87-4.39). After a systematic search in the Manu-
facturer and User Facility Device Experience Database
(MAUDE), Boyles et al. concluded that erosions consti-
tuted 60% of the complications associated with the TOT
and are probably underreported [27]. In our analysis the
only significant risk factor for erosion was the type of
sling, with a very high risk (17.8%) for the Obtape® sling
compared to the two others. The mean follow-up was dif-
ferent between the three types of slings. However, the dif-
ference in the occurrence of erosion remained significant
after adjustment for the duration in a multivariable
model. There were more per operative complications with
Aris® (12) than with Obtape® (5) which suggest that per
operative complications were not a risk factor for the
development of vaginal erosions.
We believe that vaginal erosion might be secondary to
three potential factors: the sling material, surgical tech-
nique, or individual patient factors. Our data confirm that
the tolerance of vaginal tissue depends on the type of sling
Survival analysis comparing Aris®, Obtape® ant TVT-O®  slings for the occurrence of vaginal erosion Figure 1
Survival analysis comparing Aris®, Obtape® ant TVT-
O® slings for the occurrence of vaginal erosion.
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used. The three tapes used in our study are polypropylene
monofilaments. The TVT-O® and Aris® slings are type I
meshes because they are macroporous (>75 μm). The
Obtape® sling is more of a type II mesh since the pores are
smaller (50 μm). The incidence of erosion with this sling
was very high in our study which is similar to that of other
studies if duration of follow up is taken into account
[9,10,28]. As the Obtape® sling carries an important risk of
vaginal erosion, we have abandoned its use. Type I mesh
is considered to limit the risk of erosions [13,29] because
of a lower risk of infection, a lower inflammatory
response and a better incorporation in the surrounding
tissue. Aris® and TVT-O® are both type I meshes, but they
have different mechanicals characteristics (different sizes
of pores, different elasticity). No erosions were diagnosed
after TVT-O®, but the number of women was small. Other
authors also reported a low risk using this device (0.9%-
1.8%) [10,30].
Another difference between Aris® and TVT-O® is the surgi-
cal technique, TVT-O® being an in-out procedure and Aris®
an out-in one. However, there was no statistically signifi-
cant difference for the risk of erosion between the two
techniques in our study and we are not able to determine
if the surgical technique itself plays a role in the risk of
erosion. We found only one study in which the authors
concluded that erosion rate was associated with the surgi-
cal technique. They showed that plicaturing the pubocer-
vical fascia between the sling and the vaginal mucosa
could reduce the occurrence of erosion [31].
Individual patient characteristics (age, estrogen status,
concomitant surgery, sexual activity) may play a role in
the occurrence of vaginal erosion. Unfortunately, our
study does not have the power to show differences in
these potential risk factors. A study reported that diabetes
mellitus was the only individual patient characteristic to
be associated with a higher risk of erosions (RR 8.3, 95%
CI 1.6-43.0) [13].
The strength of this study was the availability of a contin-
uous cohort of women with a mean follow-up of more
than two years and few patients lost for follow-up (6/233,
2.6%).
The limitations of our study included those typical of
studies relying on information collected using medical
files and during a telephone contact, with the risk of infor-
mation bias. To avoid these biases, standardized ques-
tions were asked to the patients. Our evaluation of
satisfaction was limited by the fact that we asked women
their views by telephone without using a more detailed
questionnaire. TOT was accompanied by another surgical
procedure in almost half of the cases which could con-
found the analysis. However, this is not the case, because
there was no difference in the occurrence of early or late
complications between women with or without concom-
itant other surgical procedure.
Conclusion
Late post operative complications are relatively frequent
after TOT and can impair patient's satisfaction. Women
should be informed of these potential complications pre-
operatively and require careful follow-up after the proce-
dure. Choice of the safest sling material is crucial as it is a
risk factor for erosion.
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